e-learning
resources
Glasgow 2004
Sunday 05.09.2004
Inflammation and tissue repair in pulmonary disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased CCL18 production in interstitial lung diseases is associated with fibrosis
A. Prasse, D. Pechkovsky, G. Zissel, J. Müller-Quernheim (Freiburg, Germany)
Source:
Annual Congress 2004 - Inflammation and tissue repair in pulmonary disease
Session:
Inflammation and tissue repair in pulmonary disease
Session type:
Poster Discussion
Number:
366
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Prasse, D. Pechkovsky, G. Zissel, J. Müller-Quernheim (Freiburg, Germany). Increased CCL18 production in interstitial lung diseases is associated with fibrosis. Eur Respir J 2004; 24: Suppl. 48, 366
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Pulmonary sarcoidosis
Related content which might interest you:
Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease
Source: Annual Congress 2011 - Epithelial cell biology
Year: 2011
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008
Increased cytokeratin-19 expression in fibrotic interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Disturbance of pro-inflammatory cytokine production in patients with cystic fibrosis lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD)
Source: Eur Respir J 2007; 30: Suppl. 51, 110s
Year: 2007
Increased BALF eosinophils and underlying interstitial lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Role of IL23 in the development of fibrotic interstitial lung disease
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Circulating monocytes from interstitial lung disease patients show an activated phenotype
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
The role of chemokines and cytokines in lung fibrosis
Source: Eur Respir Rev 2008; 17: 151-156
Year: 2008
Elevated lPLUNC1 in inflammatory lung disease is due to increased production by goblet cells
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept